Food Additives Permitted in Feed and Drinking Water of Animals; Guanidinoacetic Acid, 37037-37038 [2021-15070]
Download as PDF
Federal Register / Vol. 86, No. 132 / Wednesday, July 14, 2021 / Rules and Regulations
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA–2019–F–5401]
Food Additives Permitted in Feed and
Drinking Water of Animals;
Guanidinoacetic Acid
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Final rule.
The Food and Drug
Administration (FDA, we, or the
Agency) is amending the regulations for
food additives permitted in feed and
drinking water of animals to provide for
the safe use of guanidinoacetic acid as
a precursor of creatine in poultry feeds.
This action is in response to a food
additive petition filed by Alzchem
Trostberg GmbH.
DATES: This rule is effective July 14,
2021. See section V of this document for
further information on the filing of
objections. Submit either electronic or
written objections and requests for a
hearing on the final rule by August 13,
2021.
ADDRESSES: You may submit objections
and requests for a hearing as follows.
Please note that late, untimely filed
objections will not be considered.
Electronic objections must be submitted
on or before August 13, 2021. The
https://www.regulations.gov electronic
filing system will accept comments
until 11:59 p.m. Eastern Time at the end
of August 13, 2021. Objections received
by mail/hand delivery/courier (for
written/paper submissions) will be
considered timely if they are
postmarked or the delivery service
acceptance receipt is on or before that
date.
lotter on DSK11XQN23PROD with RULES1
SUMMARY:
Electronic Submissions
Submit electronic objections in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting objections.
Objections submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
objection will be made public, you are
solely responsible for ensuring that your
objection does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
VerDate Sep<11>2014
16:14 Jul 13, 2021
Jkt 253001
that if you include your name, contact
information, or other information that
identifies you in the body of your
objection, that information will be
posted on https://www.regulations.gov.
• If you want to submit an objection
with confidential information that you
do not wish to be made available to the
public, submit the objection as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper objections
submitted to the Dockets Management
Staff, FDA will post your objection, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–F–5401 for ‘‘Food Additives
Permitted in Feed and Drinking Water
of Animals; Guanidinoacetic Acid.’’
Received objections, those filed in a
timely manner (see ADDRESSES), will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit an objection with confidential
information that you do not wish to be
made publicly available, submit your
objections only as a written/paper
submission. You should submit two
copies in total. One copy will include
the information you claim to be
confidential with a heading or cover
note that states ‘‘THIS DOCUMENT
CONTAINS CONFIDENTIAL
INFORMATION.’’ The Agency will
review this copy, including the claimed
confidential information, in its
consideration of objections. The second
copy, which will have the claimed
confidential information redacted/
blacked out, will be available for public
viewing and posted on https://
www.regulations.gov. Submit both
copies to the Dockets Management Staff.
If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your objections and you
must identify this information as
PO 00000
Frm 00037
Fmt 4700
Sfmt 4700
37037
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper objections
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Carissa Adams, Center for Veterinary
Medicine, Food and Drug
Administration, 7519 Standish Pl.
(HFV–221), Rockville, MD 20855, 240–
402–6283, Carissa.Adams@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
In a document published in the
Federal Register of November 29, 2019
(84 FR 65717), FDA announced that we
had filed a food additive petition
(animal use) (FAP 2309) submitted by
Alzchem Trostberg GmbH, Dr.-AlbertFrank-Str. 32, 83308 Trostberg,
Germany. The petition proposed that
the regulations for food additives
permitted in feed and drinking water of
animals be amended to provide for the
safe use of guanidinoacetic acid as a
precursor of creatine in poultry feeds.
II. Conclusion
FDA concludes that the data establish
the safety and utility of guanidinoacetic
acid as a precursor of creatine in poultry
feeds and that the food additive
regulations should be amended as set
forth in this document.
III. Public Disclosure
In accordance with § 571.1(h) (21 CFR
571.1(h)), the petition and documents
we considered and relied upon in
reaching our decision to approve the
petition will be made available for
public disclosure (see FOR FURTHER
INFORMATION CONTACT). As provided in
§ 571.1(h), we will delete from the
documents any materials that are not
available for public disclosure.
IV. Analysis of Environmental Impact
We have determined under 21 CFR
25.32(r) that this action is of a type that
does not individually or cumulatively
have a significant effect on the human
E:\FR\FM\14JYR1.SGM
14JYR1
37038
Federal Register / Vol. 86, No. 132 / Wednesday, July 14, 2021 / Rules and Regulations
(i) A statement to indicate the
maximum use level of guanidinoacetic
acid must not exceed 0.12 percent of the
complete feed for poultry; and
*
*
*
*
*
environment. Therefore, neither an
environmental assessment nor an
environmental impact statement is
required.
V. Objections and Hearing Requests
Any person who will be adversely
affected by this regulation may file with
the Dockets Management Staff (see
ADDRESSES) either electronic or written
objections. Each objection shall be
separately numbered, and each
numbered objection shall specify with
particularity the provision of the
regulation to which objection is made
and the grounds for the objection. Each
numbered objection on which a hearing
is requested shall specifically so state.
Failure to request a hearing for any
particular objection shall constitute a
waiver of the right to a hearing on that
objection. Each numbered objection for
which a hearing is requested shall
include a detailed description and
analysis of the specific factual
information intended to be presented in
support of the objection in the event
that a hearing is held. Failure to include
such a description and analysis for any
particular objection shall constitute a
waiver of the right to a hearing on the
objection.
List of Subjects in 21 CFR Part 573
Animal feeds, Food additives.
Therefore, 21 CFR part 573 is
amended as follows:
1. The authority citation for part 573
continues to read as follows:
■
Authority: 21 U.S.C. 321, 342, 348.
2. In § 573.496, revise the introductory
text and paragraphs (b) and (e)(2)(i) to
read as follows:
■
lotter on DSK11XQN23PROD with RULES1
Guanidinoacetic acid.
The food additive, guanidinoacetic
acid, may be safely used in poultry
feeds in accordance with the following
prescribed conditions:
*
*
*
*
*
(b) The additive is used or intended
for use at levels not to exceed 0.12
percent of the complete feed:
(1) To spare arginine in broiler
chicken and turkey feeds; or
(2) As a precursor of creatine in
poultry feeds.
*
*
*
*
*
(e) * * *
(2) * * *
VerDate Sep<11>2014
16:14 Jul 13, 2021
Jkt 253001
[FR Doc. 2021–15070 Filed 7–13–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF LABOR
Occupational Safety and Health
Administration
29 CFR Part 1910
[Docket No. OSHA–2020–0004]
RIN 1218–AD36
Occupational Exposure to COVID–19;
Emergency Temporary Standard
Occupational Safety and Health
Administration (OSHA), Department of
Labor.
ACTION: Interim final rule; correction.
AGENCY:
OSHA is fixing minor errors
in the interim final rule published on
June 21, 2021, titled Occupational
Exposure to COVID–19; Emergency
Temporary Standard, including
correcting the docket number for
submission of comments related to
OSHA’s information collection
estimates under the Paperwork
Reduction Act.
DATES: Effective July 14, 2021.
FOR FURTHER INFORMATION CONTACT:
Press inquiries: Frank Meilinger,
Director, OSHA Office of
Communications; telephone: (202) 693–
1999; email: meilinger.francis2@dol.gov.
For technical inquiries: Maureen
Ruskin, OSHA Directorate of Standards
and Guidance; telephone: (202) 693–
1955; email: ruskin.maureen@dol.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
PART 573—FOOD ADDITIVES
PERMITTED IN FEED AND DRINKING
WATER OF ANIMALS
§ 573.496
Dated: July 7, 2021.
Janet Woodcock,
Acting Commissioner of Food and Drugs.
Dated: July 12, 2021.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
I. Summary and Explanation
On June 21, 2021, OSHA published an
interim final rule establishing an
emergency temporary standard (ETS) to
protect healthcare and healthcare
support service workers from
occupational exposure to COVID–19 in
settings where people with COVID–19
PO 00000
Frm 00038
Fmt 4700
Sfmt 4700
are reasonably expected to be present
(86 FR 32376). In the Dates section of
the preamble, the agency inadvertently
included an incorrect docket number for
submitting comments related to the
information collection estimates under
the Paperwork Reduction Act. The
agency is submitting this document to
correct this error.
In addition, in Section VI.B Economic
Feasibility, several table references were
incorrect or missing, some tables were
incorrectly numbered, and one
subsection heading was labeled
incorrectly. Those changes are shown in
the table below, titled ‘‘Table of Nonsubstantive Corrections.’’
II. Exemption From Notice-andComment Procedures
OSHA has determined that these
corrections are not subject to the
procedures for public notice and
comment specified in the
Administrative Procedure Act (5 U.S.C.
553) or Section 6(b) of the Occupational
Safety and Health Act of 1970 (29 U.S.C.
655(b)). This rulemaking only corrects
minor errors in the published rule and
does not affect or change any existing
rights or obligations. No stakeholder is
likely to object to these corrections.
Therefore, the agency finds good cause
that public notice and comment are
unnecessary under 5 U.S.C. 553(b)(3)(B),
29 U.S.C. 655(b), and 29 CFR 1911.5.
III. Correction of Publication
In FR Doc. 2021–12428 appearing in
the Federal Register of June 21, 2021
(86 FR 32376), make the following
corrections in the DATES section of the
preamble.
On page 32376, in the second column,
the second full paragraph is corrected to
read as follows:
Comments due: Written comments,
including comments on any aspect of
this ETS and whether this ETS should
become a final rule, must be submitted
by July 21, 2021 in Docket No. OSHA–
2020–0004. Comments on the
information collection determination
described in Section VII.K of the
preamble (OMB Review under the
Paperwork Reduction Act of 1995) may
be submitted by August 20, 2021 in
Docket Number OSHA–2021–0003.
In addition, the agency provides the
following table, which contains a list of
corrections of minor, non-substantive
errors into section VI.B. These changes
are to five table references within the
text, six table numbers, and one
subsection heading.
E:\FR\FM\14JYR1.SGM
14JYR1
Agencies
[Federal Register Volume 86, Number 132 (Wednesday, July 14, 2021)]
[Rules and Regulations]
[Pages 37037-37038]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15070]
[[Page 37037]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 573
[Docket No. FDA-2019-F-5401]
Food Additives Permitted in Feed and Drinking Water of Animals;
Guanidinoacetic Acid
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA, we, or the Agency) is
amending the regulations for food additives permitted in feed and
drinking water of animals to provide for the safe use of
guanidinoacetic acid as a precursor of creatine in poultry feeds. This
action is in response to a food additive petition filed by Alzchem
Trostberg GmbH.
DATES: This rule is effective July 14, 2021. See section V of this
document for further information on the filing of objections. Submit
either electronic or written objections and requests for a hearing on
the final rule by August 13, 2021.
ADDRESSES: You may submit objections and requests for a hearing as
follows. Please note that late, untimely filed objections will not be
considered. Electronic objections must be submitted on or before August
13, 2021. The https://www.regulations.gov electronic filing system will
accept comments until 11:59 p.m. Eastern Time at the end of August 13,
2021. Objections received by mail/hand delivery/courier (for written/
paper submissions) will be considered timely if they are postmarked or
the delivery service acceptance receipt is on or before that date.
Electronic Submissions
Submit electronic objections in the following way:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting objections. Objections submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your objection will be
made public, you are solely responsible for ensuring that your
objection does not include any confidential information that you or a
third party may not wish to be posted, such as medical information,
your or anyone else's Social Security number, or confidential business
information, such as a manufacturing process. Please note that if you
include your name, contact information, or other information that
identifies you in the body of your objection, that information will be
posted on https://www.regulations.gov.
If you want to submit an objection with confidential
information that you do not wish to be made available to the public,
submit the objection as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper objections submitted to the Dockets
Management Staff, FDA will post your objection, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2019-F-5401 for ``Food Additives Permitted in Feed and Drinking
Water of Animals; Guanidinoacetic Acid.'' Received objections, those
filed in a timely manner (see ADDRESSES), will be placed in the docket
and, except for those submitted as ``Confidential Submissions,''
publicly viewable at https://www.regulations.gov or at the Dockets
Management Staff between 9 a.m. and 4 p.m., Monday through Friday, 240-
402-7500.
Confidential Submissions--To submit an objection with
confidential information that you do not wish to be made publicly
available, submit your objections only as a written/paper submission.
You should submit two copies in total. One copy will include the
information you claim to be confidential with a heading or cover note
that states ``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The
Agency will review this copy, including the claimed confidential
information, in its consideration of objections. The second copy, which
will have the claimed confidential information redacted/blacked out,
will be available for public viewing and posted on https://www.regulations.gov. Submit both copies to the Dockets Management
Staff. If you do not wish your name and contact information to be made
publicly available, you can provide this information on the cover sheet
and not in the body of your objections and you must identify this
information as ``confidential.'' Any information marked as
``confidential'' will not be disclosed except in accordance with 21 CFR
10.20 and other applicable disclosure law. For more information about
FDA's posting of comments to public dockets, see 80 FR 56469, September
18, 2015, or access the information at: https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
Docket: For access to the docket to read background documents or
the electronic and written/paper objections received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852, 240-402-7500.
FOR FURTHER INFORMATION CONTACT: Carissa Adams, Center for Veterinary
Medicine, Food and Drug Administration, 7519 Standish Pl. (HFV-221),
Rockville, MD 20855, 240-402-6283, [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
In a document published in the Federal Register of November 29,
2019 (84 FR 65717), FDA announced that we had filed a food additive
petition (animal use) (FAP 2309) submitted by Alzchem Trostberg GmbH,
Dr.-Albert-Frank-Str. 32, 83308 Trostberg, Germany. The petition
proposed that the regulations for food additives permitted in feed and
drinking water of animals be amended to provide for the safe use of
guanidinoacetic acid as a precursor of creatine in poultry feeds.
II. Conclusion
FDA concludes that the data establish the safety and utility of
guanidinoacetic acid as a precursor of creatine in poultry feeds and
that the food additive regulations should be amended as set forth in
this document.
III. Public Disclosure
In accordance with Sec. 571.1(h) (21 CFR 571.1(h)), the petition
and documents we considered and relied upon in reaching our decision to
approve the petition will be made available for public disclosure (see
FOR FURTHER INFORMATION CONTACT). As provided in Sec. 571.1(h), we
will delete from the documents any materials that are not available for
public disclosure.
IV. Analysis of Environmental Impact
We have determined under 21 CFR 25.32(r) that this action is of a
type that does not individually or cumulatively have a significant
effect on the human
[[Page 37038]]
environment. Therefore, neither an environmental assessment nor an
environmental impact statement is required.
V. Objections and Hearing Requests
Any person who will be adversely affected by this regulation may
file with the Dockets Management Staff (see ADDRESSES) either
electronic or written objections. Each objection shall be separately
numbered, and each numbered objection shall specify with particularity
the provision of the regulation to which objection is made and the
grounds for the objection. Each numbered objection on which a hearing
is requested shall specifically so state. Failure to request a hearing
for any particular objection shall constitute a waiver of the right to
a hearing on that objection. Each numbered objection for which a
hearing is requested shall include a detailed description and analysis
of the specific factual information intended to be presented in support
of the objection in the event that a hearing is held. Failure to
include such a description and analysis for any particular objection
shall constitute a waiver of the right to a hearing on the objection.
List of Subjects in 21 CFR Part 573
Animal feeds, Food additives.
Therefore, 21 CFR part 573 is amended as follows:
PART 573--FOOD ADDITIVES PERMITTED IN FEED AND DRINKING WATER OF
ANIMALS
0
1. The authority citation for part 573 continues to read as follows:
Authority: 21 U.S.C. 321, 342, 348.
0
2. In Sec. 573.496, revise the introductory text and paragraphs (b)
and (e)(2)(i) to read as follows:
Sec. 573.496 Guanidinoacetic acid.
The food additive, guanidinoacetic acid, may be safely used in
poultry feeds in accordance with the following prescribed conditions:
* * * * *
(b) The additive is used or intended for use at levels not to
exceed 0.12 percent of the complete feed:
(1) To spare arginine in broiler chicken and turkey feeds; or
(2) As a precursor of creatine in poultry feeds.
* * * * *
(e) * * *
(2) * * *
(i) A statement to indicate the maximum use level of
guanidinoacetic acid must not exceed 0.12 percent of the complete feed
for poultry; and
* * * * *
Dated: July 7, 2021.
Janet Woodcock,
Acting Commissioner of Food and Drugs.
Dated: July 12, 2021.
Xavier Becerra,
Secretary, Department of Health and Human Services.
[FR Doc. 2021-15070 Filed 7-13-21; 8:45 am]
BILLING CODE 4164-01-P